This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease

Sponsored by Seoul National University Hospital

About this trial

Last updated a year ago

Study ID

H-2110-155-1266

Status

Recruiting

Type

Observational

Placebo

No

Accepting

10+ Years
All Sexes

Trial Timing

Ended 5 months ago

What is this trial about?

The goal of this observational study is to investigate characteristics of individuals at high risk for developing Inflammatory Bowel Disease (IBD) in order to identify risk factors associated with its incidence. The main question it aims to answer is: What are the risk factors for developing Inflammatory Bowel Disease? Researchers will compare groups at high risk for IBD to healthy populations and to patients already diagnosed with IBD. Participants will * undergo assessments of general demographic and clinical characteristics. * be monitored for symptoms using questionnaires administered at regular intervals. * have blood tests and stool examinations performed. In cases where participants undergo colonoscopy for routine clinical indications, gut biopsies will also be performed.

What are the participation requirements?

Inclusion Criteria

* first-degree relatives of Inflammatory Bowel Disease patients

* patients who are diagnosed with autoimmune diseases

* patients with functional gastrointestinal disorders who are ASCA-positive

Exclusion Criteria

* Patients with symptoms such as a 10% weight loss within 3 months, abdominal pain, hematochezia, or diarrhea will undergo colonoscopy, and those diagnosed with Inflammatory Bowel Disease will be excluded.

* Treatment history of Diabetes Mellitus, Irritable Bowel Syndrome, or colon cancer.